Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.0 - $10.45 $80,139 - $279,150
-26,713 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.57 - $21.72 $64,806 - $185,944
-8,561 Reduced 24.27%
26,713 $19,000
Q4 2021

Feb 15, 2022

BUY
$19.68 - $28.68 $137,760 - $200,760
7,000 Added 24.76%
35,274 $60,000
Q3 2021

Nov 15, 2021

BUY
$26.16 - $40.68 $739,647 - $1.15 Million
28,274 New
28,274 $62,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0

About Avalo Therapeutics, Inc.


  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $118M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.